Mercer Capital Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Mercer Capital Advisers's AMGN Position: Q3 2021 in Review
Mercer Capital Advisers reduced its Amgen (AMGN) stake by 6.1% in Q3 2021, selling an estimated $69K and leaving 4,633 shares worth $985K. The position accounts for 0.53% of the portfolio, ranked #35.
Mercer Capital Advisers first reported a position in AMGN in Q4 2014 and has held it in 28 quarters since. The position peaked at $1.25M in Q3 2020. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.
- Mercer Capital Advisers held 4,633 shares of Amgen worth $985K as of Q3 2021.
- Mercer Capital Advisers sold 300 Amgen shares in Q3 2021, an estimated $69K.
- Amgen made up 0.53% of Mercer Capital Advisers's portfolio in Q3 2021, its #35 holding.
- Mercer Capital Advisers first reported a position in Amgen in Q4 2014 and has held it in 28 quarters since.
- Mercer Capital Advisers's Amgen position peaked at $1.25M in Q3 2020.
- 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.
Based on Mercer Capital Advisers's 13F filing for Q3 2021, filed 27 Oct 2021.